BOSTON--(BUSINESS WIRE)--Gelesis (NYSE: GLS), the maker of Plenity for weight management, presented new preclinical data showing weight loss and additional metabolic benefits in mice receiving a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback